The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus
- 주제(키워드) Expert consensus , Biological disease-modifying antirheumatic drugs , Inflammatory arthritis , Arthritis , rheumatoid , Spondylitis , ankylosing
- 주제(기타) Medicine, General & Internal
- 설명문(일반) [Park, Eun-Jung] Natl Med Ctr, Dept Med, Div Rheumatol, Seoul, South Korea; [Kim, Hyungjin] Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Sch Med, Seoul, South Korea; [Jung, Seung Min] Yonsei Univ, Dept Med, Div Rheumatol, Coll Med, Seoul, South Korea; [Sung, Yoon-Kyoung] Hanyang Univ Hosp Rheumat Dis, Dept Rheumatol, Seoul, South Korea; [Baek, Han Joo] Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Rheumatol, Incheon, South Korea; [Lee, Jisoo] Ewha Womans Univ, Dept Internal Med, Div Rheumatol, Sch Med, 1071 Anyangcheon Ro, Seoul 07985, South Korea
- 등재 SCIE, KCI등재
- OA유형 Green Published, gold
- 발행기관 KOREAN ASSOC INTERNAL MEDICINE
- 발행년도 2020
- 총서유형 Journal
- URI http://www.dcollection.net/handler/ewha/000000166108
- 본문언어 영어
- Published As http://dx.doi.org/10.3904/kjim.2019.411
- PubMed https://pubmed.ncbi.nlm.nih.gov/31935319
초록/요약
Biological disease-modifying antirheumatic drugs (bDMARDs) are highly effective agents for the treatment of inflammatory arthritis; however, they also possess a potential risk for serious infection. Recently, with the rapid expansion of the bD-MARDs market in Korea, reports of serious adverse events related to the agents have also increased, necessitating guidance for the use of bDMARDs. Current work entitled, "Expert consensus for the use of bDMARDs drugs for inflammatory arthritis in Korea," is the first to describe the appropriate use of bDMARDs in the management of inflammatory arthritis in Korea, with an aim to provide guidance for the local medical community to improve the quality of clinical care. Twelve consensus statements regarding the use of bDMARDs for the management of rheumatoid arthritis and ankylosing spondylitis were generated. In this review, we provide detailed guidance on bDMARDs use based on expert consensus, including who should prescribe, the role of education, indications for use, and monitoring strategies for safety.
more